Global Stem Cells Market Research and Analysis

STEM CELLS MARKET INSIGHTS:

Stem cell market is expected to grow at a CAGR of 23.3% for the forecasted period of 2016-2021. The market is segmented on the basis of products, technology and application. Stem cell are undifferentiated cells which have the capability of multiplying in ‘n’ number of cells. Stem cells market are of two types- adult stem cells and embryonic stem cells. Stem cells are being studied for their unique regenerative properties. They are being used in drug discovery programs to develop new drugs and treatment methods. Stem cell research is also being used to study genetic disorders, birth defects and other growth factors. Stem cell banks are being established which store stem cells and umbilical cord blood containing stem cells. These are used for treating the individual in future. Stem cell banking is gaining popularity amongst modern day parents who opt to store their new-born’s cells to prevent any future ailments. Stem cell are being used to treat and diagnose cancer. Stem cell are great part of understanding and treating cancer; especially in children.

Stem cell is being funded by governments, NGO’s and private firms considering the great potential it has in changing the shape of healthcare. New gene editing technologies such as CRISPR are also going to boost the stem cell research and market could witness influx of a number of products.

Regionally, North America and Europe make up for 70% of the total market. North American and European companies are well funded and well equipped. More number of start-ups are emerging. These companies are also attracting a lot of investment. Asia Pacific market is expected to grow at a healthy growth rate for the forecasted period of 2016-2021. A significant amount of research is going on in countries such as India, China, Japan and Israel.

The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, patent analysis, pipeline analysis, market determinants, key company analysis, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

• Comprehensive research methodology of stem cells market
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global stem cell market
• Insights about market determinants which are stimulating the global stem cell market
• Detailed and extensive market segments with regional distribution of forecasted revenues
• Extensive profiles and recent developments of market players

MARKET SEGMENTS INCLUDED IN THE REPORT:

• Stem Cells by Products
  • Adult Stem Cell
    • Hematopoietic Stem Cell
    • Mesenchymal Stem Cell
    • Neuronal Stem Cell
    • Dental Stem Cell
    • Umbilical Cord Stem Cell
  • Human Embryonic Stem Cell
  • Induced Pluripotent Stem Cell
  • Rat Neural Stem Cell
  • Other Stem Cell
• Stem Cell by Technology
  • Stem Cell Acquisition
    • Therapeutic Cloning for Stem Cell
    • IVF Stem Cell
    • Stem Cell Culture
  • Stem Cell Cryopreservation
  • Stem Cells Expansion and Sub-Culture
• Stem Cells by Application
  • Drug Discovery and Development
  • Stem Cells Regenerative Medicine
    • Neurology Medicines
    • Orthopedics Medicines
    • Oncology Medicines
    • Hematology Medicines
    • CVD Medicines
    • Injuries Medicines
      • Wound Care Medicines
      • Spinal Cord Injury Medicines
      • Other Injury Medicines
    • Diabetes Medicines
    • Liver Disorders Medicines

Companies profiled in the report:

• ALLOSOURCE
• ANTEROGEN
• APCETH
• BIOHEART
• CELL CURE NEUROSCIENCES
• GAMIDA CELL
• MEDIPOST
• MESOBLAST
• NEOSTEM
• NEURALSTEM
• NUVASIVE
• OCATA THERAPEUTICS
• ORTHOFIX
• OSIRIS THERAPEUTICS
• PHARMICELL
• PLURISTEM THERAPEUTICS
• RELIANCE LIFE SCIENCES
• RENEURON
• RTI SURGICAL
• STEMPEUTICS